Augmentation of murine tumor necrosis factor production by amphotericin B in vitro and in vivo.
AUTOR(ES)
Tokuda, Y
RESUMO
Murine peritoneal macrophages were preincubated with amphotericin B (AMPH) and were then stimulated with bacterial lipopolysaccharide or streptococcal preparation (OK432). These macrophages produced a large amount of tumor necrosis factor. When administered to mice, the priming activity of amphotericin B for tumor necrosis factor production in vivo was also observed.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=192255Documentos Relacionados
- Binding of lysozyme to lipopolysaccharide suppresses tumor necrosis factor production in vivo.
- Lithium chloride potentiates tumor necrosis factor-mediated cytotoxicity in vitro and in vivo.
- Reduction of NO Synthase Expression and Tumor Necrosis Factor Alpha Production in Macrophages by Amphotericin B Lipid Carriers
- Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo.
- Colchicine prevents tumor necrosis factor-induced toxicity in vivo.
